A scalable mesh immunoaffinity device decouples nano-micro-macro scales to achieve flow-rate-independent CTC capture with >75% efficiency, 96% sensitivity and 100% specificity in 79 patients and 20 controls.
HER2-family signalling mechanisms, clinical implications and targeting in breast cancer
1 Pith paper cite this work. Polarity classification is still indexing.
1
Pith paper citing it
fields
q-bio.QM 1years
2022 1verdicts
UNVERDICTED 1representative citing papers
citing papers explorer
-
Flow Rate Independent Multiscale Liquid Biopsy for Precision Oncology
A scalable mesh immunoaffinity device decouples nano-micro-macro scales to achieve flow-rate-independent CTC capture with >75% efficiency, 96% sensitivity and 100% specificity in 79 patients and 20 controls.